South Korea may start “Coexisting with COVID-19” from next month
- FDA Approves Expanded Injectable Treatment Formula for Smallpox-Monkeypox
- UK and Netherlands follow Belgium to implement “monkeypox quarantine”
- European EMA removes about 100 generic drugs
- EU approves AstraZeneca’s COVID-19 vaccine as booster shot
- First injection of cancer-killing oncolytic virus into human patient
- First monkeypox quarantine order: Belgium requires to self-isolate for 21 days
South Korea may start “Coexisting with COVID-19” from next month
- Unexplained acute hepatitis in children may be related to COVID superantigens
- How long can the patient live after heart stent surgery?
- Keytruda: The 5-year survival rate for advanced lung cancer doubled!
- Amylyx released the latest statistical analysis of new ALS drugs after being opposed by FDA panel last month
- Celine Dion is paralyzed due to muscle cramps: What are Muscle Cramps?
- Taiwan death from COVID-19 vaccination exceeds death from COVID-19
- The world top 5 best-selling drugs in 2020
South Korea may start “Coexisting with COVID-19” from next month.
South Korea may take the first step of “coexisting with the COVID-19” from next month, focusing on preventing death and severe illness.
On October 1, 2021 local time, in Seoul, South Korea, people walk on the streets of South Korea under the COVID-19 epidemic. People’s Visual Information MapOn October 1, 2021 local time, in Seoul, South Korea, people walk on the streets of South Korea under the COVID-19 epidemic.
South Korea may take the first step to “coexist with the COVID-19” next month. This will be the first time the South Korean government has initiated the transformation of the epidemic prevention system since the first confirmed case of the COVID-19 in South Korea on January 20 last year.
It will shift the focus of epidemic prevention work to the management of death and critically ill patients, and relax public facilities. Restrictions on operations and private gatherings will restore daily order in stages.
According to Yonhap News Agency’s report on the 17th, Prime Minister Kim Bu-gyeom said that before deciding on the epidemic prevention response adjustment plan that day, he hoped that this would be the last time the epidemic prevention response measures were adjusted, and that daily order would be restored in stages starting from November.
As of this weekend, the inoculation rate of the COVID-19 vaccine in South Korea has reached 70%, which meets the core conditions for the transformation of the epidemic prevention system.
According to reports, the South Korean government will gradually relax restrictions on living facilities, large-scale events, and private gatherings in accordance with the vaccination rate in different periods, but the basic rules of “maintaining social distance” and wearing masks will still be maintained.
In addition, the “vaccine pass” system will also be implemented for a limited time in public facilities such as performance venues and sports fields where the risk of epidemic transmission is relatively high.
The report pointed out that although the number of new confirmed cases in a single day after the policy adjustment may reach 4,000 to 5,000, the South Korean government will still work to restore daily order.
As the rate of severely ill patients has fallen sharply, the government has also formulated a home treatment plan. If oral specific drugs are officially released, the rate of home treatment patients will further increase.
However, the biggest variable in restoring daily order is the emergence of new mutant strains, and it is also very important to formulate an epidemic prevention plan to deal with unpredictable emergencies.
If there is a mutated virus with fast spreading speed, high vaccine tolerance and high fatal rate in the future, and a pandemic that is far beyond the tolerance of society continues, it is necessary to take additional preventive measures.
South Korea may start “Coexisting with COVID-19” from next month
(source:internet, reference only)
Disclaimer of medicaltrend.org
